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As you probably know by now we are working on a report on GaN and related materials. Compiling 
the market forecast for this half-formed sector - it still can't be said to have formed an industry as yet 
- has not been easy. It is troublesome enough sorting out the technology and which player is doing 
what - because it's cards against the chest time - but when you throw in licensing and patents it 
becomes almost impossible. I was already worried that the market might never take shape and I have 
so far not been disavowed of this. At this point in time there are signs that there might be a market - 
a big market - but other factors may conspire to throttle it back so that it takes longer than everyone 
expects to fulfil its potential. 
B 
asically, there have been two 
principal players in the many- 
act play that is the wide band- 
gap semiconductor business: Cree for 
SiC and Nichia for GaN. Cree was first 
out with the SiC LED and through 
that reawakened a dormant market 
for blue LEDs. Soon after, however, 
the world was rocked by the debut of 
the Nichia blue LED based on GaN. 
While these devices and their target 
appl icat ions have commonal i t ies ,  
there are manyy differences and in par- 
ticular about how these companies 
have decided to operate. In fact they 
are complete opposites.  Cree was 
quick to licence its SiC patented tech- 
nologies to a portfolio of large cor- 
porat ions wor ldwide whilst at the 
same time selling its own materials 
and devices. It is also involved in not 
a few collaborations with government 
and commercial  labs. Nichia, how- 
ever, is hanging on to its in-house de- 
veloped technology and defending all- 
comers over the patents. It refuses to 
licence any of the GaN patents and 
has said it will sue anyone sell ing 
GaN optoelectronics  based on its 
technology. Already it has announced 
intentions to take to court rival Japa- 
nese company Toyoda Gosei. This 
could prove a test case watched closely 
by everyone. 
i suppose it's all down to business 
and making sure that you get a return 
on your investment .  However ,  it 
makes one question whether this is all 
in the best interest of the industry that 
is still to form. There are two special 
points here that it is worth bringing 
out for a critical comment. First, the 
matter of whether Cree's SiC has had 
its day and maybe history will show 
that the company was right to licence 
its technology. Because ultimately it 
might  not amount  to very much. 
Bluntly, the licence-takers have been 
sold a deal of goods. That's the risk 
they take and it looks as if given the 
Nichia stance then they had no choice. 
They could not have gone to Nichia 
and secured the same deal. The tech- 
nology is not for sale. It's going to be 
tough to develop their own. Not only 
is the technology a close secret but also 
anything matching the Nichia patents 
will be contested in court. So the other 
players teased by knowing that it can 
be done will have to expend much ef- 
fort and expense in f inding ways 
around it all. But time is against hem 
and the race is heating up. Maybe you 
can't afford not to compete. 
But I wonder whether this is not in 
the best overall ong-term interests of 
this fledgling business? For all its skills 
in originating this technology Nichia 
is not an optoelectronics device com- 
pany. It is a chemicals company. It un- 
derstands that business very well but is 
having to learn the opto business fast. 
Moreover, it is an open secret hat the 
key process technology at Nichia, i.e. 
the epitaxy, is not yet in full mass-pro- 
duction. Certainly, the company is 
making good money from what it can 
sell - $200 million last year - but 
having set off the goldrush it cannot 
keep up with demand. It doesn't have 
the technology nor the infrastructure 
to make the most of the business. Nor 
it appears, is it prepared to share with 
someone who can. I cannot be alone in 
thinking that this is neither in the best 
longer-term interests of Nichia nor 
will it be the making of the industry. 
One is reminded of the personal com- 
puter business - IBM's acceptance of 
PC clones which freed the market o 
expand at its own pace - to become 
the zillion dollar industry it is today. 
Compare this with the fate of Apple, 
the company that refused to licence 
its architecture. 
Sadly, if you keep it all to yourself 
you stand to lose it all in the long run. 
Is this analogy pertinent to the Nichia 
vs Cree stance? In some respects, yes 
but it is imperfect. PCs created a new 
market whereas there has long been a 
pent-up demand for good blue LEDs. 
So will there be a GaN optoelec- 
tronics business if there is but one 
player? Will people buy when there is 
a single source? Remember the Sumi- 
tomo resin fire and the Kobe earth- 
quake. . ,  not  hav ing  p lura l i ty  of  
supply makes you pause before com- 
mitting to a device like this. After all, 
without a secure supply of blues your 
display is useless.., noTVs, no laptops, 
no big-screens, etc. etc. At the mo- 
ment it looks like other players will 
have catch up and fast.., or there may 
be no business to look forward to. For 
anyone, Nichia included. 
I am forced to wonder what would 
happen if such a situation were to arise 
with a cancer-cure...? 
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